CSPC Innovation Pharmaceutical Co., Ltd. (300765.SZ)
CNY 27.6
(-0.11%)
CNY 27.6
(-0.11%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 1.64 Million CNY | -91.77% |
| 2022 | 20.02 Million CNY | 2280.93% |
| 2021 | 840.95 Thousand CNY | -87.35% |
| 2020 | 6.64 Million CNY | -46.78% |
| 2019 | 12.48 Million CNY | -82.31% |
| 2018 | 70.58 Million CNY | -26.27% |
| 2017 | 95.73 Million CNY | -20.22% |
| 2016 | 120 Million CNY | 0.0% |
| 2015 | 120 Million CNY | 0.0% |
| 2014 | - CNY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q3 | 78.6 Million CNY | -99.67% |
| 2024 Q1 | 1.44 Million CNY | -12.04% |
| 2024 Q2 | 65.03 Million CNY | 4388.34% |
| 2023 Q1 | 19.92 Million CNY | -0.5% |
| 2023 FY | 1.64 Million CNY | -91.77% |
| 2023 Q4 | 1.64 Million CNY | -10.59% |
| 2023 Q3 | 1.84 Million CNY | -91.61% |
| 2023 Q2 | 21.95 Million CNY | 10.21% |
| 2022 Q3 | 213.66 Thousand CNY | -49.73% |
| 2022 FY | 20.02 Million CNY | 2280.93% |
| 2022 Q4 | 20.02 Million CNY | 9271.16% |
| 2022 Q1 | 634.11 Thousand CNY | -24.6% |
| 2022 Q2 | 425.02 Thousand CNY | -32.97% |
| 2021 Q1 | 1.44 Million CNY | 0.0% |
| 2021 Q4 | 840.95 Thousand CNY | -19.57% |
| 2021 FY | 840.95 Thousand CNY | -87.35% |
| 2021 Q2 | 1.24 Million CNY | -13.83% |
| 2021 Q3 | 1.04 Million CNY | -16.22% |
| 2020 FY | 6.64 Million CNY | -46.78% |
| 2020 Q1 | - CNY | 0.0% |
| 2020 Q2 | - CNY | 0.0% |
| 2020 Q3 | - CNY | 0.0% |
| 2020 Q4 | - CNY | 0.0% |
| 2019 Q4 | - CNY | 0.0% |
| 2019 FY | 12.48 Million CNY | -82.31% |
| 2019 Q2 | 50 Million CNY | -28.78% |
| 2019 Q1 | 70.2 Million CNY | -0.55% |
| 2019 Q3 | - CNY | -100.0% |
| 2018 Q1 | - CNY | -100.0% |
| 2018 Q4 | 70.58 Million CNY | 0.0% |
| 2018 Q2 | 70.34 Million CNY | 0.0% |
| 2018 FY | 70.58 Million CNY | -26.27% |
| 2017 Q4 | 95.73 Million CNY | 0.0% |
| 2017 FY | 95.73 Million CNY | -20.22% |
| 2017 Q1 | 47.42 Million CNY | 0.0% |
| 2017 Q2 | 47.42 Million CNY | 0.0% |
| 2017 Q3 | 95.73 Million CNY | 101.89% |
| 2016 FY | 120 Million CNY | 0.0% |
| 2015 FY | 120 Million CNY | 0.0% |
| 2014 FY | - CNY | 0.0% |